Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Galectin Therapeutics Inc., 3 years.
Galectin Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 2025 | Galectin Therapeutics Inc. | Open-market purchase | +5,500 | $3.55 | $19,525 |
| Jul 17, 2025 | Galectin Therapeutics Inc. | Open-market purchase | +5,000 | $2.90 | $14,500 |
| Dec 24, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +10,000 | $0.81 | $8,100 |
| Oct 17, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +1,300 | $2.64 | $3,432 |
| Oct 16, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +5,000 | $2.70 | $13,500 |
| Oct 16, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +5,000 | $2.70 | $13,500 |
| Jun 20, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +2,500 | $2.38 | $5,950 |
| Apr 22, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +2,500 | $2.98 | $7,450 |
| Apr 9, 2024 | Galectin Therapeutics Inc. | Inheritance | +2,063 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.